1-3 of 3
Thomas Staudinger, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Emicizumab for the Treatment of Acquired Hemophilia_A: Lessons Learned from 4 Very Different Cases

Paul Knoebl, MD, Wolfgang R. Sperr, Peter Schellongowski, MD, Thomas Staudinger, MD, Petra Jilma-Stohlawetz, MD, Peter Quehenberger, MD, Silvia Koder, Ing, Cihan Ay, MD, Karoline V. Gleixner, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2476.
https://doi.org/10.1182/blood-2018-99-116973
Published: 2018
Journal Articles

Incidence of Intensive Care Unit Admission, Outcome, and Post Intensive Care Survival in Patients with Acute Lymphocytic Leukemia or Burkitt Lymphoma

Peter Schellongowski, MD, Philipp Wohlfarth, MD, Kundi Michael, MD, Alexander Hauswirth, MD, Andja Bojic, MD, Werner Rabitsch, MD, Ulrich Jäger, MD, Peter Valent, MD, Thomas Staudinger, MD, Wolfgang R. Sperr
Journal: Blood
Blood (2014) 124 (21): 2633.
https://doi.org/10.1182/blood.V124.21.2633.2633
Published: 2014
Journal Articles

Treatment Of Infection-Associated Purpura Fulminans With Protein C Zymogen Is Associated With a High Survival Rate

Paul Knoebl, MD, Peter Schellongowski, MD, Thomas Staudinger, MD, Wolfgang R. Sperr, MD, Christian Scheibenpflug, MD
Journal: Blood
Blood (2013) 122 (21): 3606.
https://doi.org/10.1182/blood.V122.21.3606.3606
Published: 2013